Potential health and economic impacts of dexamethasone treatment for patients with COVID-19
Ricardo Aguás(University of Oxford), Talant Abdyldaev(Kyrgyz State Medical Academy), Yu Nandar Aung(London School of Economics and Political Science), Lisa J. White(University of Oxford), Amel H. Salim(International Trachoma Initiative), Sayed Ataullah Saeedzai(Ministry of Public Health), Aida Estebesova, Emmanuel A. Bakare(Federal University Oye Ekiti), João Martins(Universidade da Paz), Renato Mendes Coutinho(Universidade Federal do ABC), Antônio Ximenes(Universidade da Paz), Fatima Arifi(World Health Organization - Afghanistan), Yuki Yunanda(Universitas Sumatera Utara), Ainura Kutmanova(The Ministry of Education and Science of the Kyrgyz Republic), Biniam Getachew(World Health Organization - Nigeria), Sana Eybpoosh(Pasteur Institute of Iran), Ivana Alona(Universitas Sumatera Utara), Nantasit Luangasanatip(Mahidol University), Semeeh Akinwale Omoleke(World Health Organization - Nigeria), Handoyo Harsono, Inke Nadia Diniyanti Lubis(Universitas Sumatera Utara), Ainura Moldokmatova(University of Oxford), Antoninho Benjamin Monteiro(Universidade da Paz), Peter Horby, Adam Mahdi(University of Oxford), K. C. Sarin(Ministry of Public Health), O. Celhay(Ithaca College), Amirah Azzeri(Universiti Sains Islam Malaysia), Dipti Lata(Nepal Development Research Institute), Sai Thein Than Tun(University of Oxford), Rima Shretta(University of Oxford), Nathaniel Hupert(New York Hospital Queens), Grace Wezi Mzumara(Ministry of Health), Akindeh M. Nji(Université de Yaoundé I), Mohammad Nadir Sahak(World Health Organization - Afghanistan), Mahnaz Hossain Fariba(People's University of Bangladesh), Wirichada Pan–ngum(Mahidol University), Martin Landray, Hamid Sharifi(Kerman University of Medical Sciences), Amen-Patrick Nwosu(University of Oxford), Siyu Chen(University of Oxford), José Luís Herrera(Johns Hopkins University), Mofakhar Hussain(University of Toronto), Phetsavanh Chanthavilay(University of Health Sciences Vientiane), Chynar Zhumalieva(Kyrgyz Economic University), Merita Monteiro(Charles Darwin University), Penny Hancock(University of Oxford), Keyrellous Adib(University of Nottingham), Aizhan Dooronbekova(Kyrgyz Economic University), Hakim Bekrizadeh(Payame Noor University)
Cited by 68
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k